Relationship between blood levels of N-carboxymethyl-lysine and pentosidine and the severity of microangiopathy in type 2 diabetes

被引:50
作者
Hirata, K [1 ]
Kubo, K [1 ]
机构
[1] Hiroshima Prefectural Hosp, Dept Endocrine & Renal Med, Minami Ku, Hiroshima 7348530, Japan
关键词
diabetic nephropathy; diabetic retinopathy; N-carboxymethyl-lysine; pentosidine;
D O I
10.1507/endocrj.51.537
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The relationship between blood levels of N-carboxymethyl-lysine (CML) or pentosidine and the severity of microangiopathy was investigated in patients with type 2 diabetes. Blood CML and pentosidine levels were measured by ELISA in 97 type 2 diabetics (46 men and 51 women). CML and pentosidine levels were significantly higher in patients with chronic renal failure than in those with normoalbuminuria, microalbuminuria, or macroalbuminuria (all p<0.05). Among the diabetics without nephropathy (n = 49), blood CML levels were significantly higher in the patients who had proliferative diabetic retinopathy than in those without retinopathy or those who had background retinopathy (both p<0.01). In contrast, blood pentosidine levels showed no significant differences among the three retinopathy groups. These findings suggest that the blood level of CML is related to the severity of both nephropathy and retinopathy, while the pentosidine level is only related to the severity of nephropathy.
引用
收藏
页码:537 / 544
页数:8
相关论文
共 21 条
[1]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[2]   FORMATION OF IMMUNOCHEMICAL ADVANCED GLYCOSYLATION END-PRODUCTS PRECEDES AND CORRELATES WITH EARLY MANIFESTATIONS OF RENAL AND RETINAL DISEASE IN DIABETES [J].
BEISSWENGER, PJ ;
MAKITA, Z ;
CURPHEY, TJ ;
MOORE, LL ;
JEAN, S ;
BRINCKJOHNSEN, T ;
BUCALA, R ;
VLASSARA, H .
DIABETES, 1995, 44 (07) :824-829
[3]   INCREASED COLLAGEN-LINKED PENTOSIDINE LEVELS AND ADVANCED GLYCOSYLATION END-PRODUCTS IN EARLY DIABETIC NEPHROPATHY [J].
BEISSWENGER, PJ ;
MOORE, LL ;
BRINCKJOHNSEN, T ;
CURPHEY, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (01) :212-217
[4]   Advanced glycation end products in serum predict changes in the kidney morphology of patients with insulin-dependent diabetes mellitus [J].
Berg, TJ ;
Bangstad, HJ ;
Torjesen, PA ;
Osterby, R ;
Bucala, R ;
Hanssen, KF .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1997, 46 (06) :661-665
[5]   Increased urinary levels of pentosidine, pyrraline and acrolein adduct in type 2 diabetes [J].
Daimon, M ;
Sugiyama, K ;
Kameda, W ;
Saitoh, T ;
Oizumi, T ;
Hirata, A ;
Yamaguchi, H ;
Ohnuma, H ;
Igarashi, M ;
Kato, T .
ENDOCRINE JOURNAL, 2003, 50 (01) :61-67
[6]  
DYER DG, 1991, J BIOL CHEM, V266, P11654
[7]   Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy [J].
Endo, M ;
Yanagisawa, K ;
Tsuchida, K ;
Okamoto, T ;
Matsushita, T ;
Higuchi, M ;
Matsuda, A ;
Takeuchi, M ;
Makita, Z ;
Koike, T .
HORMONE AND METABOLIC RESEARCH, 2001, 33 (05) :317-322
[8]   Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients [J].
Kiuchi, K ;
Nejima, J ;
Takano, T ;
Ohta, M ;
Hashimoto, H .
HEART, 2001, 85 (01) :87-91
[9]   ADVANCED GLYCOSYLATION END-PRODUCTS IN PATIENTS WITH DIABETIC NEPHROPATHY [J].
MAKITA, Z ;
RADOFF, S ;
RAYFIELD, EJ ;
YANG, Z ;
SKOLNIK, E ;
DELANEY, V ;
FRIEDMAN, EA ;
CERAMI, A ;
VLASSARA, H .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (12) :836-842
[10]   MAILLARD REACTION-PRODUCTS AND THEIR RELATION TO COMPLICATIONS IN INSULIN-DEPENDENT DIABETES-MELLITUS [J].
MCCANCE, DR ;
DYER, DG ;
DUNN, JA ;
BAILIE, KE ;
THORPE, SR ;
BAYNES, JW ;
LYONS, TJ .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) :2470-2478